GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (FRA:NZCA) » Definitions » Cash Flow from Discontinued Operations

Provexis (FRA:NZCA) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Provexis Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Provexis's cash flow from discontinued operations for the six months ended in Sep. 2023 was €0.00 Mil. It means Provexis received €0.00 Mil from the sale of part of business quarterly. Provexis's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2023 was €0.00 Mil.

Provexis Cash Flow from Discontinued Operations Historical Data

The historical data trend for Provexis's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Cash Flow from Discontinued Operations Chart

Provexis Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Provexis Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Provexis Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Provexis Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Provexis's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Provexis (FRA:NZCA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (FRA:NZCA) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
LSE:CHLL AQSE:ANA LSE:STX LSE:HELD LSE:N4P AQSE:APOL LSE:VLG LSE:CEL XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB BOM:532321 TSE:4507
Traded in Other Exchanges
PXS.GB:UK PXS:UK
Address
2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Website
https://www.provexis.com
Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is a patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.

Provexis (FRA:NZCA) Headlines

No Headlines